Search Within

Nursing

  1. "Journal of Thoracic Oncology"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (6)
Groups
  1. Department of Medicine (14)
  2. Solid Tumor Oncology Division (13)
  3. Thoracic Oncology (13)
  4. Survivorship Research (9)
  5. Body Imaging Service (7)
  6. Radiology, Department of (7)

More Groups

People
  1. Mark Kris (6)
  2. Lee Krug (5)
  3. Michelle Ginsberg (5)
  4. Charles Rudin (4)
  5. Andrew Plodkowski (3)
  6. Bernard Park (3)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (1)
  4. 2018 (2)
  5. 2017 (1)
  6. 2013 (3)

More Years

Publications
  1. Journal of Thoracic Oncology (15)
Publishers
  1. Elsevier Inc. (15)

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk and outcomes of secondary malignancy among non-small cell lung cancer survivors following definitive treatment
    Meeting Abstract

    Yariv, O.; Raoof, S.; Isbell, J. M.; Park, B. J.; Jones, D. R.; Shaverdian, N.; Ruggiero, J.; Jackson, U.; Li, B.; Iyengar, P.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228
    Journal Article

    Paik, P. K.; Fan, P. D.; Qeriqi, B.; Namakydoust, A.; Daly, B.; Ahn, L.; Kim, R.; Plodkowski, A.; Ni, A.; Chang, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Brief Report: Chylothorax and chylous ascites during RET tyrosine kinase inhibitor therapy
    Journal Article

    Kalchiem-Dekel, O.; Falcon, C. J.; Bestvina, C. M.; Liu, D.; Kaplanis, L. A.; Wilhelm, C.; Eichholz, J.; Harada, G.; Wirth, L. J.; Digumarthy, S. R.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Targeting NFE2L2 mutations in advanced squamous cell lung cancers with the TORC1/2 inhibitor TAK-228
    Meeting Abstract

    Paik, P.; Ahn, L.; Ginsberg, M.; McFarland, D.; Doyle, L.; Rudin, C.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • A phase II trial of albumin-bound paclitaxel and gemcitabine in patients with newly diagnosed stage IV squamous cell lung cancers
    Meeting Abstract

    Paik, P.; Kim, R.; Ahn, L.; Plodkowski, A.; Ng, K.; McFarland, D.; Iqbal, A.; Eng, J.; Rudin, C.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • A phase 2 study of cabozantinib for patients with advanced RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A.; Somwar, R.; Smith, R.; Delasos, L.; Albano, M.; Van Voorthuyson, M.; Wang, L.; Rekhtman, N.; Ni, A.; Plodkowski, A.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Safety of hemithoracic pleural intensity-modulated radiation therapy (IMRT) for malignant pleural mesothelioma (MPM) in the multimodality setting: Interim analysis of a phase II study
    Meeting Abstract

    Wu, A. J.; Zauderer, M. G.; Gomez, D.; Rosenzweig, K. E.; Foster, A.; Yorke, E.; Rice, D.; Tsao, A.; Rusch, V. W.; Krug, L. M.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • A phase II trial of paclitaxel, pemetrexed and bevacizumab in patients with untreated, advanced lung cancers
    Meeting Abstract

    Pietanza, M. C.; Hellmann, M. D.; Rizvi, N.; Azzoli, C. G.; Smith-Marrone, S.; Fiore, J.; Tyson, L. B.; Sumner, D. K.; Hergianto, A. B.; Kass, S. L.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Exercise and lung cancer survivorship
    Meeting Abstract

    Corcoran, S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: Safety and efficacy in a phase 1 trial
    Journal Article

    Azzoli, C. G.; Patel, J. D.; Krug, L. M.; Miller, V.; James, L.; Kris, M. G.; Ginsberg, M.; Subzwari, S.; Tyson, L.; Dunne, M.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save